Literature DB >> 18439858

Thalidomide therapy in a patient with thalassemia major.

Lilia Beatriz Aguilar-Lopez, José Luis Delgado-Lamas, Benjamín Rubio-Jurado, Francisco Javier Perea, Bertha Ibarra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18439858     DOI： 10.1016/j.bcmd.2008.03.001

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN： 1079-9796            Impact factor:   3.039


× No keyword cloud information.
  8 in total

1.  Optimal response to thalidomide in a patient with thalassaemia major resistant to conventional therapy.

Authors:  Nicoletta Masera; Luisa Tavecchia; Marietta Capra; Giovanni Cazzaniga; Chiara Vimercati; Lorena Pozzi; Andrea Biondi; Giuseppe Masera
Journal:  Blood Transfus       Date:  2010-01       Impact factor: 3.443

Review 2.  Foetal haemoglobin inducers and thalassaemia: novel achievements.

Authors:  Roberto Gambari
Journal:  Blood Transfus       Date:  2010-01       Impact factor: 3.443

3.  Experience with combination of hydroxyurea and low-dose thalidomide in transfusion-dependent beta thalassemia patients.

Authors:  Dinesh Bhurani; Jyotsna Kapoor; Neha Yadav; Vishvdeep Khushoo; Narendra Agrawal; Rayaz Ahmed; Jatinder Singh Arora; Pallavi Mehta
Journal:  Ann Hematol       Date:  2021-04-03       Impact factor: 3.673

Review 4.  Ineffective Erythropoiesis in β-Thalassaemia: Key Steps and Therapeutic Options by Drugs.

Authors:  Filomena Longo; Andrea Piolatto; Giovanni Battista Ferrero; Antonio Piga
Journal:  Int J Mol Sci       Date:  2021-07-05       Impact factor: 5.923

Review 5.  Erythropoiesis: insights into pathophysiology and treatments in 2017.

Authors:  Andrea Zivot; Jeffrey M Lipton; Anupama Narla; Lionel Blanc
Journal:  Mol Med       Date:  2018-03-23       Impact factor: 6.354

6.  Safety and efficacy of thalidomide in patients with transfusion-dependent β-thalassemia: a randomized clinical trial.

Authors:  Jiang-Ming Chen; Wei-Jian Zhu; Jie Liu; Gui-Zhen Wang; Xiao-Qin Chen; Yun Tan; Wei-Wei Xu; Li-Wei Qu; Jin-Yan Li; Huan-Ju Yang; Lan Huang; Ning Cai; Wei-Da Wang; Ken Huang; Jian-Quan Xu; Guo-Hui Li; Sheng He; Tian-Ying Luo; Yi Huang; Song-Hua Liu; Wen-Qiang Wu; Qi-Yang Lu; Mei-Guang Zhou; Shu-Ying Chen; Rong-Lan Li; Mei-Ling Hu; Ying Huang; Jin-Hua Wei; Jun-Min Li; Sai-Juan Chen; Guang-Biao Zhou
Journal:  Signal Transduct Target Ther       Date:  2021-11-18

Review 7.  Pharmacological Induction of Fetal Hemoglobin in β-Thalassemia and Sickle Cell Disease: An Updated Perspective.

Authors:  Rayan Bou-Fakhredin; Lucia De Franceschi; Irene Motta; Maria Domenica Cappellini; Ali T Taher
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-16

8.  Thalidomide for Patients with β-Thalassemia: A Multicenter Experience.

Authors:  Kun Yang; Yi Wu; Yali Zhou; Binbin Long; Qian Lu; Tianhong Zhou; Li Wang; Zhili Geng; Xiaolin Yin
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-05-01       Impact factor: 2.576
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.